Depletion of RBMS1 alleviates oxaliplatin chemoresistance in gastric cancer cells by suppressing the efflux function of ABCB1
Abstract Despite its declining overall incidence, gastric cancer (GC) remains a major global health challenge as the third leading cause of cancer-related mortality. In particular, the prognosis for advanced GC patients is quite unsatisfactory, largely due to the development of chemoresistance. Here...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2026-08-01
|
| Ráidu: | European Journal of Medical Research |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s40001-026-05052-x |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
